Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma

Clinical Colorectal Cancer

Volumn 11, Issue 3, 2012, Pages 185-190

  Morse, Michael A ^a   Hanks, Brent A ^a   Suhocki, Paul ^a   Doan, Phuong L ^a   Liu, Emily A ^a   Frost, Patricia ^a   Bernard, Stephen A ^b   Tsai, Andrea ^c   Moore, Dominic T ^b   O'Neil, Bert H ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cirrhosis; Doxorubicin; Lipiodol; Mitomycin C; Polyvinyl alcohol particles

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; DOXORUBICIN; MITOMYCIN C;

ADOLESCENT; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CHEMOEMBOLIZATION; DISEASE COURSE; FEMALE; FOLLOW UP; HEPATIC ARTERY; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SCORING SYSTEM; TUMOR VOLUME;

EID: 84865500128     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2011.11.003     Document Type: Article

References (19)

1. American Cancer Society Global Cancer Facts and Figures 2008 http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/ document/acspc-027766.pdf Accessed December 21, 2011
2. M.B. Thomas, A.X. Zhu Hepatocellular carcinoma: the need for progress J Clin Oncol 23 2005 2892
3. J. Bruix, M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
4. C.M. Lo, H. Ngan, W.K. Tso Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171
5. J.M. Llovet, M.I. Real, X. Montana Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739
6. J.M. Llovet, J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 2003 429 442
7. C. Camma, F. Schepis, A. Orlando Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials Radiology 224 2002 47 54
8. L. Marelli, R. Stigliano, C. Triantos Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30 2007 6 25
9. P.M. Lopez, A. Villanueva, J.M. Llovet Systematic review: evidence based management of hepatocellular carcinomaan updated analysis of randomized controlled trials Aliment Pharmacol Ther 23 2006 1535 1547
10. J.M. Llovet, A.M. Di Bisceglie, J. Bruix Design and endpoints of clinical trials in hepatocellular carcinoma J Natl Cancer Inst 100 2008 698 711
11. M.K.B. Parmar Survival Analysis: A Practical Approach 2nd ed. 2006 Wiley West Sussex, England
12. D.W. Hosmer, S. Lemeshow Applied Survival Analysis: Regression Modeling of Time to Event Data 1999 John Wiley & Sons Hoboken, NJ
13. D.R. Cox Regression models and life-tables J Roy Statist Soc Ser B 34 1972 187 220
14. R.E. Kass, A.E. Raftery Bayes factors J Am Stat Assoc 90 1995 773 795
15. E.L. Kaplan, P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
16. R Development Core Team R: A language and environment for statistical computing R News 3 2008 http://www.R-project.org
17. S. Kawai, J. Okamura, M. Ogawa Prospective and randomized clinical trial for the treatment of hepatocellular carcinomaa comparison of lipiodol-transcatheter arterial embolization with and without Adriamycin (first cooperative study) Cancer Chemother Pharmacol 31 1992 1 6
18. J.M. Chang, W.S. Tzeng, H.B. Pan Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma A randomized controlled study Cancer 74 1994 2449 2453
19. H. Shen, D. Agarwal, R. Qi Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization Aliment Pharmacol Ther 26 2007 393 400